<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">nnp</journal-id><journal-title-group><journal-title xml:lang="en">Neurology, Neuropsychiatry, Psychosomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>Неврология, нейропсихиатрия, психосоматика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2711</issn><issn pub-type="epub">2310-1342</issn><publisher><publisher-name>"IMA-Press", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/2074-2711-2024-1S-38-44</article-id><article-id custom-type="elpub" pub-id-type="custom">nnp-2381</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ И МЕТОДИКИ</subject></subj-group></article-categories><title-group><article-title>Analysis of migraine characteristics in postmenopausal women</article-title><trans-title-group xml:lang="ru"><trans-title>Анализ особенностей мигрени у женщин в постменопаузе</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-3192-1936</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Климентова</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Klimentova</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Диана Андреевна Климентова</p><p>119021, Москва, ул. Россолимо, 11, стр. 1</p></bio><bio xml:lang="en"><p>Diana Andreevna Klimentova</p><p>11, Rossolimo St., Build. 1, Moscow 119021</p></bio><email xlink:type="simple">klimentovadiana23@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5827-9428</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Косивцова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kosivtsova</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119021, Москва, ул. Россолимо, 11, стр. 1</p></bio><bio xml:lang="en"><p>11, Rossolimo St., Build. 1, Moscow 119021</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7142-3719</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сергеев</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sergeev</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119021, Москва, ул. Россолимо, 11, стр. 1</p></bio><bio xml:lang="en"><p>11, Rossolimo St., Build. 1, Moscow 119021</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3833-532X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Табеева</surname><given-names>Г. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Tabeeva</surname><given-names>G. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>119021, Москва, ул. Россолимо, 11, стр. 1</p></bio><bio xml:lang="en"><p>11, Rossolimo St., Build. 1, Moscow 119021</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Кафедра нервных болезней и нейрохирургии Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Department of Nervous Diseases and Neurosurgery, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>19</day><month>10</month><year>2024</year></pub-date><volume>16</volume><issue>1S</issue><issue-title>Спецвыпуск: Головная боль</issue-title><fpage>38</fpage><lpage>44</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Klimentova D.A., Kosivtsova O.V., Sergeev A.V., Tabeeva G.R., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Климентова Д.А., Косивцова О.В., Сергеев А.В., Табеева Г.Р.</copyright-holder><copyright-holder xml:lang="en">Klimentova D.A., Kosivtsova O.V., Sergeev A.V., Tabeeva G.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nnp.ima-press.net/nnp/article/view/2381">https://nnp.ima-press.net/nnp/article/view/2381</self-uri><abstract><sec><title>Objective</title><p>Objective: to identify characteristics of migraine in women in postmenopause (PM) by analyzing the frequency, duration and intensity of migraine attacks, assessment of quality of life, anxiety, depression and sleep disturbances in patients in the reproductive phase (RP) and in the PM.</p></sec><sec><title>Material and methods</title><p>Material and methods. The study comprised 60 migraine patients (30 patients in the RP, 30 patients in the PM). During the personal interview, age, migraine type, frequency and duration of attacks and headache (HA) intensity on the visual analogue scale (VAS) were recorded. The patients then completed the questionnaires: HIT-6, MIBS-4, HURT, Migraine- ACT, MIDAS, SF-36, HADS, ISQ. The statistical analysis was performed in Microsoft Office Excel 2021.</p></sec><sec><title>Results</title><p>Results. The risk of high intensity HA (≥8 points on the VAS) was significantly higher in patients in the PM than in patients in the RP [p&lt;0.05; relative risk (RR) 1.77]. The risk of necessity of a revision of therapy of attacks was higher in the PM than in the RP (p=0.004; RR=2.2). The risk of insomnia was higher in the PM than in the RP (p=0.004; RR=4.67). The risk of severe headache impact (HIT-6) and high migraine burden (MIBS-4) was higher in patients in the PM than in the RP (ORHIT6=1.7; ORMIBS4=1.78). All indicators of SF-36 quality of life questionnaire were significantly lower in patients in the PM group than in the RP group (p&lt;0.05). The risk of subclinical and clinical anxiety (p&lt;0.05; RR=4.33) and depression (p&lt;0.05; RR=2.75) was significantly higher in the PM than in the RP.</p></sec><sec><title>Conclusion</title><p>Conclusion. Migraine attacks in women in the PM are more intense than in women in the RP, quality of life is lower, and revision of therapy for attacks is required more frequently. Patients with migraine in the PM are more likely to suffer from anxiety, depression and insomnia. Further research is needed to determine the causes of the observed phenomena and to develop migraine therapy in patients in the PM.</p></sec></abstract><trans-abstract xml:lang="ru"><p>Цель исследования – выявление особенностей течения мигрени в постменопаузе (ПМ) на основе анализа частоты, продолжительности и интенсивности приступов мигрени, оценки качества жизни, тревоги, депрессии и нарушений сна у пациенток в репродуктивном периоде (РП) и в ПМ.</p><sec><title>Материал и методы</title><p>Материал и методы. В исследование включено 60 пациенток с мигренью (30 пациенток – в РП, 30 пациенток – в ПМ). При очном анкетировании регистрировались возраст, форма мигрени, частота и длительность приступов, интенсивность головной боли (ГБ) по визуальной аналоговой шкале (ВАШ). Далее пациентки заполняли опросники: HIT-6, MIBS-4, HURT, Migraine-ACT, MIDAS, SF-36, HADS, ISQ. Статистическая обработка проводилась в программе Microsoft Office Excel 2021.</p></sec><sec><title>Результаты</title><p>Результаты. Среди пациенток в ПМ риск ГБ высокой интенсивности (≥8 баллов по ВАШ) значимо выше, чем в РП [p&lt;0,05; относительный риск (ОР) 1,77]. Риск необходимости пересмотра терапии приступов в ПМ был выше, чем в РП (p=0,004; ОР=2,2). Риск бессонницы в ПМ выше, чем в РП (p=0,004; ОР=4,67). Риск тяжелого влияния ГБ (HIT-6) и высокого уровня бремени мигрени (MIBS-4) у пациенток в ПМ выше, чем в РП (ОРHIT6=1,7; ОРMIBS4=1,78). Все показатели опросника качества жизни SF-36 были значимо ниже у пациенток в ПМ по сравнению с группой в РП (p&lt;0,05). Риск субклинической и клинической тревоги (p&lt;0,05; ОР=4,33) и депрессии (p&lt;0,05; ОР=2,75) был значимо выше в ПМ, чем в РП.</p></sec><sec><title>Заключение</title><p>Заключение. Приступы мигрени у женщин в ПМ интенсивнее, чем в РП, качество жизни – ниже, чаще требуется пересмотр терапии приступов. Пациентки с мигренью в ПМ чаще страдают тревогой, депрессией и бессонницей. Для выявления причин наблюдаемых феноменов и разработки терапии у пациенток с мигренью в ПМ необходимы дальнейшие исследования.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>мигрень</kwd><kwd>постменопауза</kwd><kwd>репродуктивный период</kwd><kwd>тревога</kwd><kwd>депрессия</kwd><kwd>качество жизни</kwd><kwd>бессонница</kwd></kwd-group><kwd-group xml:lang="en"><kwd>migraine</kwd><kwd>postmenopause</kwd><kwd>reproductive period</kwd><kwd>anxiety</kwd><kwd>depression</kwd><kwd>quality of life</kwd><kwd>insomnia</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ripa P, Ornello R, Degan D, et al. Migraine in menopausal women: a systematic review. Int J Womens Health. 2015 Aug 20;7:773-82. doi: 10.2147/IJWH.S70073</mixed-citation><mixed-citation xml:lang="en">Ripa P, Ornello R, Degan D, et al. Migraine in menopausal women: a systematic review. Int J Womens Health. 2015 Aug 20;7:773-82. doi: 10.2147/IJWH.S70073</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Pavlovic JM. The impact of midlife on migraine in women: summary of current views. Womens Midlife Health. 2020 Oct 6;6:11. doi: 10.1186/s40695-020-00059-8</mixed-citation><mixed-citation xml:lang="en">Pavlovic JM. The impact of midlife on migraine in women: summary of current views. Womens Midlife Health. 2020 Oct 6;6:11. doi: 10.1186/s40695-020-00059-8</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Neri I, Granella F, Nappi R, et al. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas. 1993 Jul;17(1):31-7. doi: 10.1016/0378-5122(93)90121-w</mixed-citation><mixed-citation xml:lang="en">Neri I, Granella F, Nappi R, et al. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas. 1993 Jul;17(1):31-7. doi: 10.1016/0378-5122(93)90121-w</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Карпова МИ, Заряда АА, Долгушина ВФ и др. Мигрень у женщин: клинические и терапевтические аспекты. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;119(3):98-107. doi: 10.17116/jnevro201911903198</mixed-citation><mixed-citation xml:lang="en">Karpova MI, Zariada AA, Dolgushina VF, et al. Migraine in women: clinical and therapeutical aspects. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(3):98-107. doi: 10.17116/jnevro201911903198 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Makita K, Inagaki M, Kitamura S, Tatsuoka Y. Changes in migraine before and after menopause in Japanese climacteric women. Cephalalgia. 2017 Oct;37(11):1088-92. doi: 10.1177/0333102416653234. Epub 2016 Jun 2.</mixed-citation><mixed-citation xml:lang="en">Makita K, Inagaki M, Kitamura S, Tatsuoka Y. Changes in migraine before and after menopause in Japanese climacteric women. Cephalalgia. 2017 Oct;37(11):1088-92. doi: 10.1177/0333102416653234. Epub 2016 Jun 2.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cupini LM, Matteis M, Troisi E, et al. Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia. 1995 Apr;15(2):140-4. doi: 10.1046/j.1468-2982.1995.015002140.x</mixed-citation><mixed-citation xml:lang="en">Cupini LM, Matteis M, Troisi E, et al. Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia. 1995 Apr;15(2):140-4. doi: 10.1046/j.1468-2982.1995.015002140.x</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ornello R, Caponnetto V, Frattale I, Sacco S. Patterns of Migraine in Postmenopausal Women: A Systematic Review. Neuropsychiatr Dis Treat. 2021 Mar 19;17:859-71. doi: 10.2147/NDT.S285863</mixed-citation><mixed-citation xml:lang="en">Ornello R, Caponnetto V, Frattale I, Sacco S. Patterns of Migraine in Postmenopausal Women: A Systematic Review. Neuropsychiatr Dis Treat. 2021 Mar 19;17:859-71. doi: 10.2147/NDT.S285863</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Martin VT, Pavlovic J, Fanning KM, et al. Perimenopause and Menopause Are Associated With High Frequency Headache in Women With Migraine: Results of the American Migraine Prevalence and Prevention Study. Headache. 2016 Feb;56(2):292-305. doi: 10.1111/head.12763. Epub 2016 Jan 21.</mixed-citation><mixed-citation xml:lang="en">Martin VT, Pavlovic J, Fanning KM, et al. Perimenopause and Menopause Are Associated With High Frequency Headache in Women With Migraine: Results of the American Migraine Prevalence and Prevention Study. Headache. 2016 Feb;56(2):292-305. doi: 10.1111/head.12763. Epub 2016 Jan 21.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Saffari TM, Kavanagh K, Ormseth B, et al. Severe obesity is associated with increased migraine severity and frequency: A retrospective cohort study. J Clin Neurosci. 2023 Sep;115:8-13. doi: 10.1016/j.jocn.2023.07.007. Epub 2023 Jul 14.</mixed-citation><mixed-citation xml:lang="en">Saffari TM, Kavanagh K, Ormseth B, et al. Severe obesity is associated with increased migraine severity and frequency: A retrospective cohort study. J Clin Neurosci. 2023 Sep;115:8-13. doi: 10.1016/j.jocn.2023.07.007. Epub 2023 Jul 14.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">MacGregor EA, Barnes D. Migraine in a specialist menopause clinic. Climacteric. 1999 Sep;2(3):218-23. doi: 10.3109/13697139909038065</mixed-citation><mixed-citation xml:lang="en">MacGregor EA, Barnes D. Migraine in a specialist menopause clinic. Climacteric. 1999 Sep;2(3):218-23. doi: 10.3109/13697139909038065</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Mattsson P. Hormonal factors in migraine: a population-based study of women aged 40 to 74 years. Headache. 2003 Jan;43(1):27-35. doi: 10.1046/j.1526-4610.2003.03005.x</mixed-citation><mixed-citation xml:lang="en">Mattsson P. Hormonal factors in migraine: a population-based study of women aged 40 to 74 years. Headache. 2003 Jan;43(1):27-35. doi: 10.1046/j.1526-4610.2003.03005.x</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Wang SJ, Fuh JL, Lu SR, et al. Migraine prevalence during menopausal transition. Headache. 2003 May;43(5):470-8. doi: 10.1046/j.1526-4610.2003.03092.x</mixed-citation><mixed-citation xml:lang="en">Wang SJ, Fuh JL, Lu SR, et al. Migraine prevalence during menopausal transition. Headache. 2003 May;43(5):470-8. doi: 10.1046/j.1526-4610.2003.03092.x</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Carturan P, Scorcine C, Fragoso YD. Migraine in the post-menopausal period is associated with higher levels of mood disorders, disability, and more menopausal symptoms. Arq Neuropsiquiatr. 2016 Dec;74(12):999-1002. doi: 10.1590/0004-282X20160153</mixed-citation><mixed-citation xml:lang="en">Carturan P, Scorcine C, Fragoso YD. Migraine in the post-menopausal period is associated with higher levels of mood disorders, disability, and more menopausal symptoms. Arq Neuropsiquiatr. 2016 Dec;74(12):999-1002. doi: 10.1590/0004-282X20160153</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Luo J. Association between migraine and anxiety symptoms: Results from the study of women's health across the nation. J Affect Disord. 2021 Dec 1;295:1229-33. doi: 10.1016/j.jad.2021.09.036. Epub 2021 Sep 17.</mixed-citation><mixed-citation xml:lang="en">Luo J. Association between migraine and anxiety symptoms: Results from the study of women's health across the nation. J Affect Disord. 2021 Dec 1;295:1229-33. doi: 10.1016/j.jad.2021.09.036. Epub 2021 Sep 17.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Babateen O, Althobaiti FS, Alhazmi MA, et al. Association of Migraine Headache With Depression, Anxiety, and Stress in the Population of Makkah City, Saudi Arabia: A Cross-Sectional Study. Cureus. 2023 May 31;15(5):e39788. doi: 10.7759/cureus.39788</mixed-citation><mixed-citation xml:lang="en">Babateen O, Althobaiti FS, Alhazmi MA, et al. Association of Migraine Headache With Depression, Anxiety, and Stress in the Population of Makkah City, Saudi Arabia: A Cross-Sectional Study. Cureus. 2023 May 31;15(5):e39788. doi: 10.7759/cureus.39788</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Alwhaibi M, Balkhi B, AlRuthia Y. Anxiety and depression and health-related quality of life among adults with migraine: a National Population-Based Study. Front Public Health. 2023 Oct 4;11:1241800. doi: 10.3389/fpubh.2023.1241800</mixed-citation><mixed-citation xml:lang="en">Alwhaibi M, Balkhi B, AlRuthia Y. Anxiety and depression and health-related quality of life among adults with migraine: a National Population-Based Study. Front Public Health. 2023 Oct 4;11:1241800. doi: 10.3389/fpubh.2023.1241800</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Nesbitt AD. Comorbidities of migraine: Sleep disorders. Handb Clin Neurol. 2024;199:525-34. doi: 10.1016/B978-0-12-823357-3.00020-3</mixed-citation><mixed-citation xml:lang="en">Nesbitt AD. Comorbidities of migraine: Sleep disorders. Handb Clin Neurol. 2024;199:525-34. doi: 10.1016/B978-0-12-823357-3.00020-3</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Chu S, Wu Z, Wu Z, et al. Association Between Insomnia and Migraine Risk: A Case-Control and Bidirectional Mendelian Randomization Study. Pharmgenomics Pers Med. 2021 Aug 13;14:971-6. doi: 10.2147/PGPM.S305780</mixed-citation><mixed-citation xml:lang="en">Chu S, Wu Z, Wu Z, et al. Association Between Insomnia and Migraine Risk: A Case-Control and Bidirectional Mendelian Randomization Study. Pharmgenomics Pers Med. 2021 Aug 13;14:971-6. doi: 10.2147/PGPM.S305780</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Lee W, Shin HJ, Min IK, et al. Shared comorbidity of depression, migraine, insomnia, and fibromyalgia in a population-based sample. J Affect Disord. 2024 Jun 1;354:619-26. doi: 10.1016/j.jad.2024.03.077. Epub 2024 Mar 15.</mixed-citation><mixed-citation xml:lang="en">Lee W, Shin HJ, Min IK, et al. Shared comorbidity of depression, migraine, insomnia, and fibromyalgia in a population-based sample. J Affect Disord. 2024 Jun 1;354:619-26. doi: 10.1016/j.jad.2024.03.077. Epub 2024 Mar 15.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Yoo A, Vgontzas A, Chung J, et al. The association between multidimensional sleep health and migraine burden among patients with episodic migraine. J Clin Sleep Med. 2023 Feb 1;19(2):309-17. doi: 10.5664/jcsm.10320</mixed-citation><mixed-citation xml:lang="en">Yoo A, Vgontzas A, Chung J, et al. The association between multidimensional sleep health and migraine burden among patients with episodic migraine. J Clin Sleep Med. 2023 Feb 1;19(2):309-17. doi: 10.5664/jcsm.10320</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Salari N, Hasheminezhad R, Hosseinian-Far A, et al. Global prevalence of sleep disorders during menopause: a meta-analysis. Sleep Breath. 2023 Oct;27(5):1883-97. doi: 10.1007/s11325-023-02793-5. Epub 2023 Mar 9.</mixed-citation><mixed-citation xml:lang="en">Salari N, Hasheminezhad R, Hosseinian-Far A, et al. Global prevalence of sleep disorders during menopause: a meta-analysis. Sleep Breath. 2023 Oct;27(5):1883-97. doi: 10.1007/s11325-023-02793-5. Epub 2023 Mar 9.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Hachul H, Hachul de Campos B, Lucena L, Tufik S. Sleep During Menopause. Sleep Med Clin. 2023 Dec;18(4):423-33. doi: 10.1016/j.jsmc.2023.06.004. Epub 2023 Jul 16.</mixed-citation><mixed-citation xml:lang="en">Hachul H, Hachul de Campos B, Lucena L, Tufik S. Sleep During Menopause. Sleep Med Clin. 2023 Dec;18(4):423-33. doi: 10.1016/j.jsmc.2023.06.004. Epub 2023 Jul 16.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Tasnim S, Nyholt DR. Migraine and thyroid dysfunction: Co-occurrence, shared genes and biological mechanisms. Eur J Neurol. 2023 Jun;30(6):1815-27. doi: 10.1111/ene.15753. Epub 2023 Mar 9.</mixed-citation><mixed-citation xml:lang="en">Tasnim S, Nyholt DR. Migraine and thyroid dysfunction: Co-occurrence, shared genes and biological mechanisms. Eur J Neurol. 2023 Jun;30(6):1815-27. doi: 10.1111/ene.15753. Epub 2023 Mar 9.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Dev P, Favas TT, Jaiswal R, et al. The effect of low dose thyroid replacement therapy in patients with episodic migraine and subclinical hypothyroidism: A randomised placebocontrolled trial. Cephalalgia. 2023 Oct;43(10):3331024231182684. doi: 10.1177/03331024231182684</mixed-citation><mixed-citation xml:lang="en">Dev P, Favas TT, Jaiswal R, et al. The effect of low dose thyroid replacement therapy in patients with episodic migraine and subclinical hypothyroidism: A randomised placebocontrolled trial. Cephalalgia. 2023 Oct;43(10):3331024231182684. doi: 10.1177/03331024231182684</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Faubion SS, Smith T, Thielen J, et al. Association of Migraine and Vasomotor Symptoms. Mayo Clin Proc. 2023 May;98(5):701-12. doi: 10.1016/j.may-ocp.2023.01.010</mixed-citation><mixed-citation xml:lang="en">Faubion SS, Smith T, Thielen J, et al. Association of Migraine and Vasomotor Symptoms. Mayo Clin Proc. 2023 May;98(5):701-12. doi: 10.1016/j.may-ocp.2023.01.010</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">MacDonald CJ, El Fatouhi D, Madika AL, et al. Association of Migraine With Incident Hypertension After Menopause: A Longitudinal Cohort Study. Neurology. 2021 Jul 6;97(1):e34-e41. doi: 10.1212/WNL.0000000000011986. Epub 2021 Apr 21.</mixed-citation><mixed-citation xml:lang="en">MacDonald CJ, El Fatouhi D, Madika AL, et al. Association of Migraine With Incident Hypertension After Menopause: A Longitudinal Cohort Study. Neurology. 2021 Jul 6;97(1):e34-e41. doi: 10.1212/WNL.0000000000011986. Epub 2021 Apr 21.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Godley F 3rd, Meitzen J, Nahman-Averbuch H, et al. How Sex Hormones Affect Migraine: An Interdisciplinary Preclinical Research Panel Review. J Pers Med. 2024 Feb 7;14(2):184. doi: 10.3390/jpm14020184</mixed-citation><mixed-citation xml:lang="en">Godley F 3rd, Meitzen J, Nahman-Averbuch H, et al. How Sex Hormones Affect Migraine: An Interdisciplinary Preclinical Research Panel Review. J Pers Med. 2024 Feb 7;14(2):184. doi: 10.3390/jpm14020184</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Nappi RE, Tiranini L, Sacco S, et al. Role of Estrogens in Menstrual Migraine. Cells. 2022 Apr 15;11(8):1355. doi: 10.3390/cells11081355</mixed-citation><mixed-citation xml:lang="en">Nappi RE, Tiranini L, Sacco S, et al. Role of Estrogens in Menstrual Migraine. Cells. 2022 Apr 15;11(8):1355. doi: 10.3390/cells11081355</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Rustichelli C, Bellei E, Bergamini S, et al. Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study. Cephalalgia. 2020 Oct;40(12):1355-62. doi: 10.1177/0333102420937742. Epub 2020 Jun 26.</mixed-citation><mixed-citation xml:lang="en">Rustichelli C, Bellei E, Bergamini S, et al. Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study. Cephalalgia. 2020 Oct;40(12):1355-62. doi: 10.1177/0333102420937742. Epub 2020 Jun 26.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Mattsson P. Serum levels of androgens and migraine in postmenopausal women. Clin Sci (Lond). 2002 Nov;103(5):487-91. doi: 10.1042/cs1030487</mixed-citation><mixed-citation xml:lang="en">Mattsson P. Serum levels of androgens and migraine in postmenopausal women. Clin Sci (Lond). 2002 Nov;103(5):487-91. doi: 10.1042/cs1030487</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Aegidius KL, Zwart JA, Hagen K, et al. Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study. Eur J Neurol. 2007 Jan;14(1):73-8. doi: 10.1111/j.1468-1331.2006.01557.x</mixed-citation><mixed-citation xml:lang="en">Aegidius KL, Zwart JA, Hagen K, et al. Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study. Eur J Neurol. 2007 Jan;14(1):73-8. doi: 10.1111/j.1468-1331.2006.01557.x</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
